Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Mar;47(3):209–213. doi: 10.1136/jcp.47.3.209

Assessment of proliferative activity in leukaemic bone marrow using the monoclonal antibody Ki-67.

D M White 1, A G Smith 1, J L Smith 1
PMCID: PMC501896  PMID: 8163690

Abstract

AIMS--To investigate proliferative activity in leukaemic and lymphomatous bone marrow infiltrates and to assess the feasibility of transport of specimens among institutions. METHODS--Proliferative activity in bone marrow trephine cryosections from 99 patients with non-Hodgkin's lymphoma (NHL), 23 patients with acute myeloid leukaemia (AML), 11 with acute lymphoblastic leukaemia (ALL), and two with acute undifferentiated leukaemia (AUL) was investigated. Infiltration was seen in 52 out of 99 cases of NHL on bone marrow cryosections. A score was devised to assess pathological infiltrates in bone marrow trephine cryosections using the monoclonal antibody Ki-67. This method of scoring gave a measure of non-erythroid proliferative activity. RESULTS--Mean Ki-67 positivity in bone marrow infiltrates in 31 low grade B cell lymphomas (Kiel classification) was 0.3% before and 4.7% after treatment, 16.4% in seven high grade B cell lymphomas, and 17.8% in 12 peripheral T cell lymphomas. In 48 cases of NHL, bone marrow cryosections had not been infiltrated, and in all but one case the percentage of Ki-67 positive cells in normal marrow was less than 3%; the remaining case showed coexistent myelodysplasia and 8% bone marrow Ki-67 positivity. In eight cases of common ALL at diagnosis, the mean Ki-67 positivity in marrow cryosections was 24.9%, significantly higher than the 2.4% Ki-67 positivity seen in AML (p < 0.05). One of the two cases of common ALL with less than 1% Ki-67 positivity was refractory to treatment. CONCLUSIONS--Proliferative activity of erythroid elements in the bone marrow varies greatly. Immunostaining of bone marrow cryosections using Ki-67 permits accurate assessment of non-erythroid proliferative activity in lymphomas and leukaemia. High grade B cell lymphomas and peripheral T cell lymphomas invading the marrow have very similar mean proliferative activities. Such levels of proliferation are of the same order as those seen in common ALL, but much higher than those seen in AML.

Full text

PDF
209

Images in this article

210Image
on p.210
211Image
on p.211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campana D., Janossy G. Proliferation of normal and malignant human immature lymphoid cells. Blood. 1988 May;71(5):1201–1210. [PubMed] [Google Scholar]
  2. Chatelain C., Burstein S. A., Harker L. A. Lithium enhancement of megakaryocytopoiesis in culture: mediation via accessory marrow cells. Blood. 1983 Jul;62(1):172–176. [PubMed] [Google Scholar]
  3. Dow L. W., Chang L. J., Tsiatis A. A., Melvin S. L., Bowman W. P. Relationship of pretreatment lymphoblast proliferative activity and prognosis in 97 children with acute lymphoblastic leukemia. Blood. 1982 Jun;59(6):1197–1202. [PubMed] [Google Scholar]
  4. Falini B., Canino S., Sacchi S., Ciani C., Martelli M. F., Gerdes J., Stein H., Pileri S., Gobbi M., Fagioli M. Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies. Br J Haematol. 1988 Jul;69(3):311–320. doi: 10.1111/j.1365-2141.1988.tb02368.x. [DOI] [PubMed] [Google Scholar]
  5. Gerdes J., Lemke H., Baisch H., Wacker H. H., Schwab U., Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984 Oct;133(4):1710–1715. [PubMed] [Google Scholar]
  6. Gerdes J., Stein H., Pileri S., Rivano M. T., Gobbi M., Ralfkiaer E., Nielsen K. M., Pallesen G., Bartels H., Palestro G. Prognostic relevance of tumour-cell growth fraction in malignant non-Hodgkin's lymphomas. Lancet. 1987 Aug 22;2(8556):448–449. doi: 10.1016/s0140-6736(87)90977-9. [DOI] [PubMed] [Google Scholar]
  7. Hart J. S., George S. L., Frei E., 3rd, Bodey G. P., Nickerson R. C., Freireich E. J. Prognotic significance of pretreatment proliferative activity in adult acute leukemia. Cancer. 1977 Apr;39(4):1603–1617. doi: 10.1002/1097-0142(197704)39:4<1603::aid-cncr2820390435>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  8. Hiddemann W., Büchner T., Andreeff M., Wörmann B., Melamed M. R., Clarkson B. D. Cell kinetics in acute leukemia: a critical reevaluation based on new data. Cancer. 1982 Jul 15;50(2):250–258. doi: 10.1002/1097-0142(19820715)50:2<250::aid-cncr2820500215>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  9. Murphy S. B., Dahl G. V., George S. L., Karas J., Look A. T., Simone J. V., Mauer A. M. Determination of the significance of in vitro blast cell [3H]thymidine labelling indices obtained initially and serially during induction therapy of acute non-lymphocytic leukemia. Leuk Res. 1982;6(5):639–648. doi: 10.1016/0145-2126(82)90079-0. [DOI] [PubMed] [Google Scholar]
  10. Neckers L. M., Funkhouser W. K., Trepel J. B., Cossman J., Gratzner H. G. Significant non-S-phase DNA synthesis visualized by flow cytometry in activated and in malignant human lymphoid cells. Exp Cell Res. 1985 Feb;156(2):429–438. doi: 10.1016/0014-4827(85)90549-x. [DOI] [PubMed] [Google Scholar]
  11. Pileri S., Gerdes J., Rivano M., Tazzari P. L., Magnani M., Gobbi M., Stein H. Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumours: a critical comparison of the monoclonal antibodies OKT9 and Ki-67. Br J Haematol. 1987 Mar;65(3):271–276. doi: 10.1111/j.1365-2141.1987.tb06853.x. [DOI] [PubMed] [Google Scholar]
  12. Preisler H. D., Azarnia N., Raza A., Grunwald H., Vogler R., Browman G., Goldberg J., Chervenick P., Miller K., Brennan J. Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia. Br J Haematol. 1984 Mar;56(3):399–407. doi: 10.1111/j.1365-2141.1984.tb03970.x. [DOI] [PubMed] [Google Scholar]
  13. Preisler H. D., Raza A., Larson R. A. Alteration of the proliferative rate of acute myelogenous leukemia cells in vivo in patients. Blood. 1992 Nov 15;80(10):2600–2603. [PubMed] [Google Scholar]
  14. Riccardi A., Danova M., Montecucco C., Ucci G., Cassano E., Giordano M., Mazzini G., Giordano P. Adult acute non-lymphoblastic leukaemia: reliability and prognostic significance of pretreatment bone marrow S-phase size determined by flow cytofluorometry. Scand J Haematol. 1986 Jan;36(1):11–17. doi: 10.1111/j.1600-0609.1986.tb02643.x. [DOI] [PubMed] [Google Scholar]
  15. Scarffe J. H., Hann I. M., Evans D. I., Morris Jones P., Palmer M. K., Lilleyman J. S., Crowther D. Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhood. Br J Cancer. 1980 May;41(5):764–771. doi: 10.1038/bjc.1980.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. White D. M., Smith A. G., Whitehouse J. M., Smith J. L. Peripheral T cell lymphoma: value of bone marrow trephine immunophenotyping. J Clin Pathol. 1989 Apr;42(4):403–408. doi: 10.1136/jcp.42.4.403. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES